T h e r a p e u t i c I n d e x 154 – Temper tantrums – Enuresis – Attention deficit hyperactivity disorder (ADHD) • Anxiety and stress-related anxiety disorders • Mental fatigue • Senile dementia • As an adjuvant in Alzheimer’s and Parkinson’s disease • Supportive therapy in intellectual disability • As an adjuvant in epilepsy and post-stroke aphasia Dosage Children: Syrup: 1 teaspoonful (5 mL) twice daily. Tablet: 1 tablet twice daily. Dosage may be modulated in severe and chronic conditions. Adults: Tablet: 2 tablets twice daily. DS syrup (sugar-free): 1 teaspoonful (5 mL) twice daily. Dosage may be modulated in severe and chronic conditions. Adverse Effects No adverse effects have been reported. Contraindications No known contraindications. Special Precautions Mentat may enhance the effect of general anesthesia. Therefore, a brief washout period of 2 weeks is recommended prior to elective surgery. Therapeutic drug monitoring may also be required in epileptic patients. Drug Interactions No clinically or biochemically significant drug interactions have been reported. Presentation Syrup: Pilfer-proof bottle of 200 mL. DS syrup (sugar-free): Pilfer-proof bottle of 100 mL. Tablet: Sealed pack of 60 tablets. Pharmacological Actions of Principal Ingredients 1. Enhancement of memory and learning capacity: Bacopa monnieri decreases the rate of forgetting of newly acquired information. Tasks assessing attention, verbal and visual short-term memory, and the retrieval of information remain unaffected. Bacopa monnieri is well-known for its nootropic effect, and is helpful in memory- and learning-enhancing activities. Mentat® [syrup, tablet, DS syrup (sugar-free)]
RkJQdWJsaXNoZXIy MjMwNjM2Nw==